摩尔多瓦消除丙型肝炎可行且节省成本:一项模型研究
本研究改编已开发的微模拟模型,模拟摩尔多瓦2004至2050年的丙型肝炎病毒(HCV)流行,评估2030年前消除HCV的情景。
要点
- 多种策略可在摩尔多瓦2030年前消除HCV。
核心结论
- 摩尔多瓦消除HCV可行且可节省成本,但需扩大筛查和治疗资源。
研究设计与样本
- 改编已开发的微模拟模型,模拟摩尔多瓦2004至2050年的HCV流行。
- 模型结局包括HCV感染、患病率、死亡率和总护理成本(含筛查和治疗)的时间趋势。
- 评估可在2030年前消除HCV的情景。
主要发现
- 多种策略可在摩尔多瓦2030年前消除HCV。
- 与2015年相比,该情景至2030年降低HCV发病率98%、HCV相关死亡72%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Moldova, an upper-middle-income country in Eastern Europe, is facing a high burden of hepatitis C virus (HCV). Our objective was to assist the National Agency of Public Health of Moldova in planning to achieve the World Health Organization's HCV elimination goals by 2030. METHODS: This study adapted a previously developed microsimulation model to simulate the HCV epidemic in Moldova from 2004 to 2050. Model outcomes included temporal trends in HCV infection, prevalence, mortality, and total cost of care, including screening and treatment. We evaluated scenarios that could eliminate HCV by 2030. RESULTS: Multiple strategies could lead to HCV elimination in Moldova by 2030. A realistic scenario of a 20% annual screening and 80% treatment rate would require 2.75 million individuals to be screened and 65 000 treated by 2030. Compared to 2015, this program will reduce HCV incidence by 98% and HCV-related deaths by 72% in 2030. Between 2022 and 2030, this strategy would cost $17.5 million for HCV screening and treatment. However, by 2050, the health system would save >$85 million compared to no investment in elimination efforts. CONCLUSIONS: HCV elimination in Moldova is feasible and can be cost saving, but requires resources to scale HCV screening and treatment.
引用
- Aaron A, Zhong H, Hiebert L, et al. Hepatitis C Elimination in Moldova Is Feasible and Cost-Saving: A Modeling Study. J Infect Dis. 2023. PMID: 37703345. doi:10.1093/infdis/jiad138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。